M.D. Anderson Cancer Center: Skin Neoplasms trials
The registry lists 15 Skin Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 4Phase 2 6No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D MelanomaTerminatedNCT04310397Phase 2Results posted
- Neoadjuvant and Adjuvant Checkpoint BlockadeCompletedNCT02519322Phase 2Results posted
- Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic MelanomaCompletedNCT02500576Phase 2Results posted
- Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic MelanomaCompletedNCT01740557Phase 1/2Results posted
- ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the SkinCompletedNCT00054691Phase 2Results posted
- Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsTerminatedNCT03420963Phase 1
- Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesTerminatedNCT02419495Phase 1
- Ipilimumab and Imatinib Mesylate in Advanced CancerCompletedNCT01738139Phase 1
- The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)Status unknownNCT01447199
- Symptom Burden in Patients With Cancer- and Treatment-Related Skin ProblemsTerminatedNCT01193036
- Body Image Functioning Among Surgically Treated Patients With Head and Neck CancerCompletedNCT00824174
- Melanoma Detection by Oblique-Incidence Optical SpectroscopyCompletedNCT00526032
- Spectral Diagnosis of Cutaneous MalignancyCompletedNCT00476905
- Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin CancersCompletedNCT00432471Not applicable
- Imatinib Mesylate in Treating Patients With Metastatic MelanomaCompletedNCT00027586Phase 2